Status:
ACTIVE_NOT_RECRUITING
Perennial Malaria Chemoprevention (PMC) Effect Study
Lead Sponsor:
Malaria Consortium
Collaborating Sponsors:
Nigerian Institute of Medical Research
London School of Hygiene and Tropical Medicine
Conditions:
Malaria
Eligibility:
All Genders
10-24 years
Phase:
NA
Brief Summary
The Malaria Consortium Nigeria (MC) will coordinate a trial of PMC in Osun State, Nigeria with strategic support from the National Malaria Elimination Programme of the Government of Nigeria (NMEP) and...
Detailed Description
Study Design and Procedures The impact of PMC will be evaluated in a two-arm cluster-randomised controlled trial and nested case control study. The primary impact outcomes are a comparison of the inci...
Eligibility Criteria
Inclusion
- Aged 10 weeks to 24 months
- Healthy
Exclusion
- severe acute malnutrition, or
- allergic to sulphur containing medication,
- HIV positive,
- taking cotrimoxazole as prophylaxis or treatment, or SP, or other sulphur-containing medication in the previous 4 weeks, and
- children with a positive malaria RDT
Key Trial Info
Start Date :
August 8 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT06155448
Start Date
August 8 2023
End Date
December 1 2026
Last Update
December 4 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ministry of Health
Oshogbo, Osun State, Nigeria